Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents
Results vary by individual, but some may notice changes within a few weeks of treatment
Hormonal imbalances According to Dr
Choosing a balanced diet rich in fruits and vegetables, practicing sun protection, managing stress, and exploring topical or oral supplements will support skin health without the dangers of highdose infusions